ライフサイエンスコーパス: trans-activator

1 logic manipulator apart from its function as trans-activator.

2 to selective induction of pro-apoptotic UPR trans-activators.

3 rotein complexes are proposed to function as trans-activators.

4 onstrated that RIPK4 directly regulates IRF6 trans-activator activity and nuclear translocation.

5 UAS1 is bound by the trans-activator Adr1p.

6 s expressing an iron-independent form of the trans-activator, Aft1, a protein that regulates the expr

7 the gene is induced by the same iron-sensing trans-activator, Aft1p, that regulates CCC2 and FET3.

8 osaccharomyces pombe is dependent on certain trans activators and a specific nucleotide sequence, whi

9 ce the role of ATF-1 as a hypoxia-responsive trans-activator and identifies a novel regulatory progra

10 aricella-zoster virus (VZV) is a major viral trans-activator and is essential for viral growth.

11 n-2A2 (BTN2A2) are regulated by the class II trans-activator and regulatory factor X, two transcripti

12 g proteins such as Bright, a B-cell-specific trans-activator, and the Drosophila melanogaster dead ri

13 y repressed in glioblastomas, the absence of trans-activators appears to be key to the production of

14 evidence that VP16 and the promiscuous viral trans-activator (bICP0) are expressed during the escape

15 The human immunodeficiency virus type 1 Rev trans activator binds directly to unspliced viral mRNA i

16 ntly, the EICP0 and IE proteins are powerful trans-activators but do not function synergistically, (i

17 ree promoters were activated by MHC class II trans-activator, but not CREB-binding protein, whereas I

18 Tat, the viral trans-activator, can be endocytosed by uninfected cells

19 The class II trans- activator (CIITA) is the main transcriptional co-

20 Inhibition of class II trans-activator (CIITA) expression prevents embryonic tr

21 Class II trans-activator (CIITA) has been shown to be required fo

22 rated that major histocompatibility class II trans-activator (CIITA) is crucial in mediating interfer

23 critically upon the activity of the class II trans-activator (CIITA) protein.

24 STAT1, IFN-regulatory factor-1, and class II trans-activator (CIITA) to IFN-gamma.

25 tive in the transcription factor or class II trans-activator (CIITA) were used to reveal a requiremen

26 ster regulator of MHC class II, the class II trans-activator (CIITA).

27 e protein, major histocompatibility class II trans-activator (CIITA).

28 of STAT1alpha and induction of the Class II trans-activator, CIITA.

29 stimulating protein 1 (Sp1) as an important trans-activator essential for constitutive activity in c

30 ar factor 1alpha (HNF1alpha) as an obligated trans-activator for PCSK9 gene expression and demonstrat

31 says identified HNF1alpha as the predominant trans-activator for PCSK9 gene working through this sequ

32 bition is achieved through repression of the trans-activator Foxo1.

33 ed in greatly enhanced IRF6 dimerization and trans-activator function.

34 iced AP-2 variant capable of inhibiting AP-2 trans-activator function.

35 To assess whether this powerful trans-activator functions in conjunction with three othe

36 ression of mRNAs encoding the liver-enriched trans activators HNF-1, HNF-4, HNF-3 alpha, and HNF-3 be

37 ine the role played by this lineage-inducing trans-activator in the establishment and maintenance of

38 varicella-zoster virus (VZV), a major viral trans-activator, initiates the virus life cycle and is a

39 al activation of endogenous genes by a viral trans-activator is sufficient to induce gene repositioni

40 reby the human immunodeficiency virus type-1 trans-activator might impair tumor suppressor functions

41 ol AdTet expressing the reverse tetracycline trans-activator (n = 3).

42 ts of HAD, we have used the HIV-1 neurotoxin trans activator of transcription protein (Tat) to invest

43 ential for virus replication and is a potent trans activator of viral gene expression.

44 Examination of the Rev trans activators of two nonprimate lentiviruses, visna v

45 Furthermore CIITA (trans-activator of class II) of the mouse has been repor

46 gamma Lys(49) acetylation were blocked using trans-activator of HIV transcription factor 1 peptides c

47 he 26-kDa protein has now been shown to be a trans-activator of late transcription and it is the prod

48 otein and thereby facilitating its role as a trans-activator of the apoB gene.

49 , our data suggest that Ets-1 functions as a trans-activator of the DOR promoter in the neonatal mous

50 Therefore, HNF1alpha is a potent trans-activator of the mouse Oatp4 promoter.

51 ption factors, C/EBP alpha was the strongest trans-activator of the PEPCK-C gene promoter in the NIH3

52 proto-oncogene, c-Myb was investigated as a trans-activator of the topo IIalpha gene.

53 viral replication cycle as a transcriptional trans-activator of the viral long terminal repeat.

54 Sp1 [or related protein(s)] is an important trans-activator of this TATA-less promoter.

55 mmunodeficiency virus (HIV)-specific protein trans-activator of transcription (Tat) can contribute to

56 that the neurotoxic HIV-1 regulatory protein trans-activator of transcription (Tat) continues to be e

57 al and electrophysiological effects of HIV-1 trans-activator of transcription (Tat) in dopamine subty

58 he presence of viral proteins, including the trans-activator of transcription (Tat), has been reporte

59 ed a cell-permeable peptide, which we termed trans-activator of transcription (TAT)-AKAD for TAT-conj

60 peptide modified to include a TAT sequence (Trans-Activator of Transcription gene in HIV; TAT-4BB) a

61 The trans-activator of transcription or TAT gene from HIV-1

62 Pretreating LPS-injected mice with trans-activator of transcription peptide (TAT)-GILZ, a c

63 D) tagged with a protein transduction domain trans-activator of transcription was transduced in cultu

64 ate-early (IE) and EICP0 proteins are potent trans-activators of EHV-1 promoters; however, in transie

65 ucturally and immunologically highly related trans-activators of the apoB gene.

66 Sp1 (specific protein-1) and Sp3, acting as trans-activators of type I collagen expression in ANF an

67 a null mutant of another endosperm-specific trans-activator Opaque2 (O2) has been shown to be requir

68 disruption of genes for either MHC class II trans-activator or I-A beta) showed no signs of lesion d

69 y is the presence or absence of a particular trans-activator or repressor relevant in determining gen

70 lled prolamin-box (P-box), recognized by the trans-activator P-box binding factor (PBF).

71 OS gene transcription by S-nitrosylating the trans-activator PARP-1 and decreasing its binding and/or

72 get genes, including c-myc, the MHC class II trans-activator, Pax-5, and CD23b.

73 Note that the Switch trans-activator performed optimally when cloned into the

74 -1 subgenomic promoter and the 34-nucleotide trans-activator prevent expression of a reporter gene.

75 inducing survival and cell division; and as trans-activator, prolonging IFN-gamma synthesis through

76 the iron response element (IRE), and of HIV trans-activator protein (Tat) to the HIV trans-activatio

77 o the arginine-rich motif present in the Tat trans-activator protein of human immunodeficiency virus

78 59-residue stem-loop interacts with the HIV trans-activator protein Tat and other cellular factors t

79 lar factors in addition to the virus-encoded trans-activator protein Tat and the RNA element TAR.

80 groups responsible for interaction with the trans-activator protein Tat, including conformations sim

81 e acidic activation domain of the prototypic trans-activator protein VP16, can itself bind to RPA.

82 th a single vector encoding the tetracycline trans-activator protein, controlled by a constitutive pr

83 The HIV-1 trans-activator protein, Tat, is a potent activator of t

84 only short transcripts in the absence of the trans-activator protein, Tat.

85 and the chimeric TCR, under the control of a trans-activator protein-responsive promoter.

86 The mRNAs of the CCAAT/enhancer-binding trans-activator proteins (C/EBPalpha and C/EBPbeta) serv

87 CysLTRs and dicarboxylic acid receptors with trans-activator reporter gene assays.

88 is complete before the binding of end-stage trans-activators, supporting the notion that heritable c

89 using a binary lentivector system i.e., the trans-activator, Switch, and the inducible promoter-tran

90 The 34-nucleotide trans-activator (TA) located within the RNA-2 of Red clo

91 nd is repressed in the presence of the viral trans-activator Tat.

92 ding sites for NF-kappaB, Sp1, and the viral trans-activator Tat.

93 Human immunodeficiency virus (HIV)-encoded trans-activator (Tat) acts through the trans-activation

94 ukemia virus type 1 (HTLV-1) transcriptional trans-activator Tax has been demonstrated to have transf

95 y is thought to be associated with the viral trans-activator Tax.

96 man T-cell lymphotropic virus, type (HTLV)-1 trans-activator, Tax, coordinates with cAMP-responsive e

97 The human T-lymphotropic retrovirus type-I trans-activator, Tax, has been shown to interact directl

98 cell lymphotropic retrovirus type I (HTLV-I) trans-activator, Tax, interacts specifically with the ba

99 The early EICP0 protein is a powerful trans-activator that activates all classes of equine her

100 he intein-mediated splicing of an artificial trans-activator that signals to a genetic circuit contai

101 t HFH-1 must compete with other unidentified trans-activators to mediate repression.

102 GBP1 and heart-specific reverse tetracycline trans-activator transgenes, we expressed human CUGBP1 in

103 While the RNA-sequence specific HIV-1 Tat trans-activator was also shown to enhance processivity i

104 ut also revealed Sp2 to be a relatively weak trans-activator with little or no capacity for additive